Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ONO-1162 (ivabradine) Phase II in chronic heart failure
jRCT2080222297Phase 2Completed
- Sponsor
- Ono Pharmaceutical
- Start
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ivabradine in chronic heart failure (CHF) (3 arms), sponsored by Ono Pharmaceutical. Primary endpoint: Primary efficacy endpoint. Started Nov 2013; status: completed.
02
Drugs
ivabradine
03
Conditions
chronic heart failure (CHF)
Beyond the preview
Go deeper on jRCT2080222297.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222297.